Clinical Trial

Zimmer Biomet-RibFix Titan

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, single-center, non-randomized, single-cohort, post-market clinical follow-up study to confirm the safety, performance, and clinical benefits for the use of the RibFix Titan™ system implants and instrumentation) in the fusion, stabilization, and fixation of fractures in the chest wall including rib reconstructive surgical procedures, trauma, or planned osteotomies.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-03-16; most recent amendment 2026-04-15.
Trial Details
NCT Number NCT07485829
Lead Sponsor Zimmer Biomet
Collaborators: Riverpoint Medical
Conditions Rib Fracture, Rib Fracture Multiple
Enrollment 54 participants
Start Date 2026-03-31
Primary Completion 2027-07 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-21